GlassScriptPhysician profile
Rachel Cooper
NPI 1851820419
$2,976.11
in general payments reported to CMS, 2019-2025
13 companies · $1,229 in 2025
The $1,229 reported for 2025 was more than what 88% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $83.34 · 2023: $156 · 2024: $1,508 · 2025: $1,229.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,861 · Travel and Lodging: $31.58.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,861.19 |
| Travel and Lodging | $31.58 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Viiv Healthcare Company | $1,203.62 | 2023-2025 | Cabenuva, Apretude, Rukobia |
| Gilead Sciences, INC. | $873.48 | 2024-2025 | Biktarvy, Yeztugo |
| Emd Serono, INC. | $308.93 | 2024-2025 | Serostim |
| Merck Sharp & Dohme LLC | $231.76 | 2024-2025 | Pifeltro, Delstrigo, Capvaxive |
| Theratechnologies INC. | $92.01 | 2024 | Egrifta, Trogarzo |
| Organon LLC | $83.34 | 2022 | |
| Hologic Sales and Service, LLC | $46.97 | 2024-2025 | Aptima, Thinprep 2000 Processor |
| Glaxosmithkline, LLC. | $42.01 | 2024-2025 | Shingrix, Arexvy |
| Exact Sciences Corporation | $23.62 | 2025 | Cologuard Collection Kit |
| Napo Pharmaceuticals INC | $20.13 | 2025 | Mytesi |
| Medtronic, INC. | $18.11 | 2024 | Intellis Adaptivestim |
| Pfizer INC. | $16.44 | 2025 | |
| Abbvie INC. | $15.69 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rachel Cooper listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.